These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Elevated brain natriuretic peptide in septic patients without heart failure. Jones AE; Kline JA Ann Emerg Med; 2003 Nov; 42(5):714-5. PubMed ID: 14596247 [No Abstract] [Full Text] [Related]
83. Role of B-Type Natriuretic Peptide in the Early Detection of Preclinical Heart Failure - Is B-Type Natriuretic Peptide the Best Tool to Find the "Invisible Enemy"? Nogi K; Hikoso S Circ J; 2024 Apr; 88(5):740-741. PubMed ID: 38538308 [No Abstract] [Full Text] [Related]
84. Do We Really Need Another Biomarker for Heart Failure? Stempien-Otero A J Card Fail; 2017 Jun; 23(6):433. PubMed ID: 28476653 [No Abstract] [Full Text] [Related]
85. [Situations where natriuretic peptides may be useful]. Jacob J; Martín-Sanchez FJ; Herrero P; Miró O; Llorens P Aten Primaria; 2012 Dec; 44(12):739-40. PubMed ID: 22963767 [No Abstract] [Full Text] [Related]
86. In Reply: B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: Insights from the ADHERE registry. Kociol RD; Curtis LH; Hernandez AF Am Heart J; 2013 Jan; 165(1):e3. PubMed ID: 23237142 [No Abstract] [Full Text] [Related]
87. What does a B-type natriuretic peptide test show? Kim J Nursing; 2005 Jan; 35(1):26. PubMed ID: 15622180 [No Abstract] [Full Text] [Related]
88. Evolving use of B-type natriuretic peptide in clinical practice. Harrison A; Bhalla V; Gardetto N; Maisel AS Clin Chem; 2004 Sep; 50(9):1714-5. PubMed ID: 15331522 [No Abstract] [Full Text] [Related]
89. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions? Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243 [No Abstract] [Full Text] [Related]
90. [Natriuretic hormones as biomarkers for hypertension and hypertensive complications]. Shoji M; Yasujima M Nihon Rinsho; 2004 Mar; 62 Suppl 3():311-4. PubMed ID: 15171390 [No Abstract] [Full Text] [Related]
91. Influence of sampling and storage conditions on B-type natriuretic peptide immunoreactivity for 3 automated assays. Gruson D; Rousseau MF; de Coninck V; Ahn SA; Ketelslegers JM Clin Chem; 2006 Apr; 52(4):766-7. PubMed ID: 16595828 [No Abstract] [Full Text] [Related]
92. Do we really need more biomarkers? O'Connor CM JACC Heart Fail; 2013 Jun; 1(3):270-1. PubMed ID: 24621880 [No Abstract] [Full Text] [Related]
93. The role of brain natriuretic peptide during strenuous endurance exercise and appetite regulation. Condello G; Chen CY J Chin Med Assoc; 2020 Jan; 83(1):1-2. PubMed ID: 31634337 [No Abstract] [Full Text] [Related]
94. [B-type ventricular peptide]. Forteza-Rey J; García Raja A Med Clin (Barc); 2003 Sep; 121(10):381-3. PubMed ID: 14565914 [No Abstract] [Full Text] [Related]
98. B-type natriuretic peptide in the management of patients with congestive heart failure. Menon PV; Glancy DL J La State Med Soc; 2004; 156(2):78-82. PubMed ID: 15106865 [No Abstract] [Full Text] [Related]
99. B-type natriuretic peptides: applications for heart failure management in 2005. Troughton RW; Richards M Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104 [No Abstract] [Full Text] [Related]
100. B-type natriuretic peptide: where are we? Nozzoli C Ann Ital Med Int; 2005; 20(3):II-III. PubMed ID: 16250179 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]